Perfect B prescribes CJC-1295/Ipamorelin and does not prescribe Sermorelin
Regulatory authorities may receive submission applications around 2026 if trial outcomes prove favorable
Fifth, and perhaps most practically, the shutdown has reminded everyone that grey-market purchases require a different mindset than buying from established pharmacies
This product is supplied exclusively to support laboratory-based research activities and is not intended for diagnostic, therapeutic, or clinical use
Quick Reference: Injection site reactions: 15-25% (mild, resolve in 2-24 hours) Nausea: 5-10% (transient, first week) Dizziness: 3-7% (occasional, brief) Serious events: Zero documented in 100+ animal studies Typical dose: 250-500 mcg/day SubQ
Jan 15, 2026 What if the problem with your GHK-Cu results isn't the peptide itself, but how you're preparing it